Follow me on Twitter
I agree that content from Twitter will be displayed to me.

Head of Group
Director of Corporate Program
His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.
Publications
Showing entries 256 - 260 out of 331
Beyer, A, Ecker, G, Schmittner, S & Chiba, P 2006, 'A structural model for ABCG2', Drugs of the Future, vol. 31, no. Suppl A, pp. 163-164.
Ecker, G & Chiba, P 2006, 'Computational 3D elucidation of the human ABC-transporter P-glycoprotein in the post-hydrolytic state', Drugs of the Future, vol. 31, no. Suppl A.
Stuppner, H, Ecker, G & Glasl-Tazreiter, S 2006, 'Diplomstudium versus Bakkalaureat', Österreichische Apothekerzeitung, vol. 60, no. 8, pp. 397-399. <http://www.oephg.at/getbinobj.asp?id=101>
Ecker, G 2006, 'HYDRAA - a tool to implement hydrophobic moments in structure activity relationships and molecular alignment', Unknown Journal, pp. 89-90.
Ecker, G, Kopp, S, Smiesko, M & Chiba, P 2006, 'Interaction field based and hologram based QSAR analysis of propafenone-type modulators of multidrug resistance', Medicinal Chemistry, vol. 1, pp. 431-444.
Projects
Molecular Drug Targets
Hering, S. (Project Lead), Ecker, G. (Co-Lead), Maulide, N. (Co-Lead), Weinzinger, A. (Co-Lead) & Gonzalez Herrero, L. (Co-Lead)
1/12/10 → 31/12/22
Project: Research funding
